Clinical Trial Update: Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated the efficacy and safety of topical ruxolitinib cream in hidradenitis suppurativa. The study has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2024-11-01